Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) has earned a consensus recommendation of "Reduce" from the twelve research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $10.5909.
WBA has been the subject of several analyst reports. UBS Group restated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th.
Get Our Latest Report on WBA
Walgreens Boots Alliance Trading Up 0.3%
Shares of Walgreens Boots Alliance stock traded up $0.04 during trading on Friday, hitting $11.94. The stock had a trading volume of 7,572,244 shares, compared to its average volume of 5,993,019. The firm's fifty day simple moving average is $11.49 and its 200-day simple moving average is $11.10. The stock has a market cap of $10.33 billion, a PE ratio of -1.64, a PEG ratio of 1.40 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. The firm had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business earned $0.63 EPS. As a group, sell-side analysts expect that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the company. Citizens Financial Group Inc. RI purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $119,000. Cetera Investment Advisers grew its position in Walgreens Boots Alliance by 7.1% during the 2nd quarter. Cetera Investment Advisers now owns 175,916 shares of the pharmacy operator's stock worth $2,020,000 after purchasing an additional 11,674 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in Walgreens Boots Alliance by 7.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 176,028 shares of the pharmacy operator's stock worth $2,021,000 after purchasing an additional 12,003 shares during the last quarter. Empower Advisory Group LLC purchased a new stake in Walgreens Boots Alliance during the 2nd quarter worth approximately $214,000. Finally, Banco Bilbao Vizcaya Argentaria S.A. grew its position in Walgreens Boots Alliance by 11.5% during the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 244,962 shares of the pharmacy operator's stock worth $2,812,000 after purchasing an additional 25,310 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.
Walgreens Boots Alliance Company Profile
(
Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.